Search details
1.
Pediatric-type low-grade gliomas in adolescents and young adults-challenges and emerging paradigms.
Childs Nerv Syst
; 2024 May 18.
Article
in English
| MEDLINE | ID: mdl-38761264
2.
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.
Cancer Immunol Immunother
; 71(1): 153-164, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34043024
3.
PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Mod Pathol
; 35(12): 1770-1774, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36057740
4.
The epidemiology of primary and metastatic brain tumors in infancy through childhood.
J Neurooncol
; 156(2): 419-429, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-35037155
5.
DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
J Neurooncol
; 157(3): 499-510, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35384518
6.
Outcomes after first relapse of childhood intracranial ependymoma.
Pediatr Blood Cancer
; 68(8): e28930, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33565268
7.
Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.
Pediatr Blood Cancer
; 68(10): e29172, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34125480
8.
Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.
J Neurooncol
; 149(1): 113-122, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32627129
9.
Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.
J Neurooncol
; 149(2): 253-262, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32780261
10.
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
J Neurooncol
; 145(2): 375-383, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31621042
11.
Increasing value of autopsies in patients with brain tumors in the molecular era.
J Neurooncol
; 145(2): 349-355, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31571114
12.
Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.
Pediatr Blood Cancer
; 66(12): e27983, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31502379
13.
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
J Neurooncol
; 140(3): 575-582, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30173409
14.
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.
J Neurooncol
; 138(1): 199-207, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29427149
15.
The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
J Pediatr Hematol Oncol
; 38(6): 489-90, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26907647
16.
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center.
Cancer Med
; 13(8): e7154, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38629258
17.
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
Neuro Oncol
; 26(2): 348-361, 2024 02 02.
Article
in English
| MEDLINE | ID: mdl-37715730
18.
Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach.
Neoplasia
; 36: 100860, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36521378
19.
H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.
J Neuropathol Exp Neurol
; 83(1): 30-35, 2023 12 22.
Article
in English
| MEDLINE | ID: mdl-38037182
20.
Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment.
Neurooncol Adv
; 5(1): vdac182, 2023.
Article
in English
| MEDLINE | ID: mdl-36926246